MENU
EIS
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

EIS stock forecast, quote, news & analysis

The investment seeks to track the investment results of the MSCI Israel Capped Investable Market Index (IMI)... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
Nov 01, 2026

iShares MSCI Israel ETF (EIS) ETF Analysis: Financials and Technology Anchor a Concentrated Single-Country Fund

Key Takeaways

  • EIS is a passively managed exchange-traded fund (ETF) that tracks the MSCI Israel Capped Investable Market Index, spanning large-, mid-, and small-cap Israeli equities across roughly 130 holdings.
  • Financials represent about one-third of the portfolio, with technology contributing nearly one-fifth, giving the fund a distinct banking-and-innovation profile.
  • Teva Pharmaceutical, Bank Leumi, and Bank Hapoalim rank among the largest positions, while the top ten holdings account for more than half of fund assets.
  • The fund has traded in a comparatively contained range in recent months, easing roughly 6% over the trailing 30 days after reaching a late-September high.
  • Principal themes to monitor include Bank of Israel monetary policy, global technology and defense demand, and the single-country concentration risk inherent to the strategy.
  • For deeper insight into valuation levels and forward expectations, explore the fund's Price Targets and Forecast pages.
  • Discover data-driven market opportunities with Trending AI Robots.

iShares MSCI Israel ETF (EIS) Overview

The iShares MSCI Israel ETF seeks to track the investment results of the MSCI Israel Capped Investable Market Index, a free float-adjusted, market-capitalization-weighted benchmark designed to measure the large-, mid-, and small-capitalization segments of Israel's equity market. The fund is structured as a passively managed, physically replicated ETF and is classified as non-diversified, meaning a limited number of issuers can exert outsized influence on returns. Its net expense ratio is 0.59%, and assets under management (AUM) have hovered around $850 million to $875 million.

Sector exposure is heavily concentrated. Financials are the largest allocation at roughly one-third of the portfolio, followed by technology at close to one-fifth. Industrials, healthcare, real estate, and utilities each contribute a smaller, single-digit-to-low-teens share. Among the largest holdings, Teva Pharmaceutical Industries (TEVA) leads, followed by the Israeli banks Bank Leumi and Bank Hapoalim. Tower Semiconductor, Elbit Systems, Nova (NVMI), Phoenix Financial, Israel Discount Bank, Mizrahi Tefahot Bank, and Check Point Software Technologies (CHKP) round out the top positions.

Industry and Thematic Landscape

Israel's equity market reflects an economy defined by a globally competitive technology sector alongside a concentrated domestic financial system. The technology complex—spanning semiconductors, cybersecurity, and enterprise software—remains a central structural growth driver, supported by sustained global spending on digital infrastructure and artificial intelligence. Defense and aerospace names, including Elbit Systems, add exposure to a segment shaped by elevated regional security demand.

The banking and insurance names that dominate the portfolio are closely tied to the domestic interest-rate environment and the health of Israel's economy. The Bank of Israel's monetary policy stance, inflation trends, and credit growth therefore matter directly to the fund's largest positions. Because EIS is a single-country fund, its performance also reflects country-specific factors, including geopolitical developments and the broader risk appetite for Israeli assets, rather than diversified global equity dynamics alone.

Performance and Positioning Snapshot

Over recent months, EIS has moved within a relatively narrow band rather than exhibiting a strong directional trend. The fund climbed through late summer and reached a multi-month peak in late September before giving back ground. Over the trailing 30 days, the ETF eased roughly 6%, while over the trailing three months it has been essentially range-bound and modestly lower.

The pullback largely mirrored weakness across the portfolio's dominant sectors. Financial holdings, which carry the heaviest weighting, and technology names such as Teva, Nova, and Check Point account for the bulk of the fund's day-to-day movement. Because the top ten positions represent more than half of assets, swings in a handful of large banks and technology leaders can disproportionately drive the fund's net asset value (NAV) relative to more diversified international benchmarks.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors search thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. It helps users identify trending securities, breakout candidates, and new trading opportunities far more efficiently than manual screening. For investors evaluating single-country funds such as EIS, the screener offers a structured way to compare securities across industries and performance characteristics. Explore the AI Screener to streamline your research workflow.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape EIS through 2026. Interest-rate expectations remain central, given the portfolio's heavy financial-sector weighting: a higher-for-longer rate environment tends to support bank net interest margins, while an easing cycle could temper those tailwinds. Inflation and the Bank of Israel's policy response will also influence credit conditions and domestic earnings.

The technology complex is a second key driver. Global enterprise and government demand for cybersecurity, semiconductors, and AI-related infrastructure will help determine the trajectory of major holdings, while defense procurement cycles remain relevant for aerospace names. On the risk side, investors should weigh single-country concentration, valuation sensitivity after strong prior gains, and the potential for geopolitical headlines to introduce volatility. Capital flows into Israel-focused funds, regulatory developments, and the earnings cycles of the fund's largest financial and technology positions will provide additional signposts for ETF performance going forward.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for EIS with price predictions
Nov 06, 2026

EIS's RSI Indicator ascending out of oversold territory

The RSI Indicator for EIS moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where EIS advanced for three days, in 306 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

EIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EIS as a result. In 72 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for EIS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 41 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

EIS moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EIS crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

The 50-day moving average for EIS moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EIS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for EIS entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Industry description

The investment seeks to track the investment results of the MSCI Israel Capped Investable Market Index (IMI). The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index rhat is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Israel. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares MSCI Israel ETF (EIS) ETF is 6.75B. The market cap for tickers in the group ranges from 723.56M to 49.7B. TEVA holds the highest valuation in this group at 49.7B. The lowest valued company is KRNT at 723.56M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI Israel ETF (EIS) ETF was -3%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -18%. DRTS experienced the highest price growth at 5%, while USD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI Israel ETF (EIS) ETF was -23%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 46
Price Growth Rating: 55
SMR Rating: 72
Profit Risk Rating: 78
Seasonality Score: 21 (-100 ... +100)